Dave Greenwald (Deerfield)
Deerfield-backed biotech emerges from stealth with gene therapy delivery platforms from Harvard and MIT
As a PhD student at Tufts, Dave Greenwald studied the use of adeno-associated virus (AAV) vectors to deliver gene therapies to people with retinitis pigmentosa …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
